LATEST TRIALS

  • Solide Tumores
    A Phase 1 Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody Administered Alone and in Combination with Anti-PD-1 Monoclonal Antibody in Advanced Solid Tumors”
  • Melanoma, Pancreatic Cancer, Solide Tumores
    A phase Ib/II open label, multicentre study of PDR001 in combination with MCS110 in patients with advanced malignancies
  • Glioblastoma
    A Randomized Phase 2 Single Blind Study of Temozolomide plus Radiation Therapy combined with Nivolumab or Placebo in Newly Diagnosed Adult Subjects with MGMT-Methylated (tumor O6-methylguanine DNA methyltransferase)

NORDIC COOPERATION

Norway Norway Sweden Finland Aarhus Herlev Copenhagen